"Immunotherapy, Active" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Active immunization where vaccine is administered for therapeutic or preventive purposes. This can include administration of immunopotentiating agents such as BCG vaccine and Corynebacterium parvum as well as biological response modifiers such as interferons, interleukins, and colony-stimulating factors in order to directly stimulate the immune system.
| Descriptor ID |
D016233
|
| MeSH Number(s) |
E02.095.465.425.400.530 E05.478.550.600
|
| Concept/Terms |
Immunotherapy, Active- Immunotherapy, Active
- Active Immunotherapy
- Active Immunotherapies
- Immunotherapies, Active
Vaccine Therapy- Vaccine Therapy
- Therapy, Vaccine
- Therapies, Vaccine
- Vaccine Therapies
Immune RNA Manipulation- Immune RNA Manipulation
- Immune RNA Manipulations
- Manipulation, Immune RNA
- Manipulations, Immune RNA
- RNA Manipulation, Immune
- RNA Manipulations, Immune
|
Below are MeSH descriptors whose meaning is more general than "Immunotherapy, Active".
Below are MeSH descriptors whose meaning is more specific than "Immunotherapy, Active".
This graph shows the total number of publications written about "Immunotherapy, Active" by people in this website by year, and whether "Immunotherapy, Active" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunotherapy, Active" by people in Profiles.
-
Gender differences in vaccine therapy: where are we in COVID-19 pandemic? Monaldi Arch Chest Dis. 2021 Apr 08; 91(4).
-
[In subjects 16 years of age and older, is messenger RNA vaccine BNT162b2 against COVID-19 effective and safe?] Rev Med Interne. 2021 03; 42(3):227-228.
-
SARS - CoV-2: Reasons of epidemiology of severe ill disease cases and therapeutic approach using trivalent vaccine (tetanus, diphtheria and Bordetella pertussis). Med Hypotheses. 2020 Aug; 141:109779.
-
CIMAvax-EGF, a therapeutic non-small cell lung cancer vaccine. Expert Opin Biol Ther. 2018 07; 18(7):829-835.
-
Monkey Models and HIV Vaccine Research. Adv Exp Med Biol. 2018; 1075:97-124.
-
Clinical Interventions in HIV Cure Research. Adv Exp Med Biol. 2018; 1075:285-318.
-
Human papillomavirus vaccines. CMAJ. 2017 09 25; 189(38):E1212.
-
[Advantages and prospects of the use of genetic vaccines for the protection from dangerous and socially significant infections]. Vestn Ross Akad Med Nauk. 2011; (10):39-47.
-
Long term safety of IVIg therapy in multiple sclerosis: 10 years experience. Autoimmunity. 2006 Sep; 39(6):513-7.